Dimethyl Fumarate Reduces Methylglyoxal-derived Carbonyl Stress Through Nrf2/GSH Activation in SH-SY5Y Cells

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Neurochemical Research

• Publication date

  2024-11-22

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/s11064-024-04255-0PMID 39576418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NRF2 in kidney physiology and disease

  2024cited by this paper
• Activators of Nrf2 to Counteract Neurodegenerative Diseases

  2023cited by this paper
• Schizophrenia and Glutathione: A Challenging Story

  2023cited by this paper
• An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases

  2022cited by this paper
• KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential

  2022cited by this paper
• Dicarbonyl stress, protein glycation and the unfolded protein response

  2021cited by this paper
• Combined glyoxalase 1 dysfunction and vitamin B6 deficiency in a schizophrenia model system causes mitochondrial dysfunction in the prefrontal cortex

  2021cited by this paper
• Accumulation of Carbonyl Proteins in the Brain of Mouse Model for Methylglyoxal Detoxification Deficits

  2021cited by this paper
• Dimethyl Fumarate Mitigates Tauopathy in Aβ-Induced Neuroblastoma SH-SY5Y Cells

  2020cited by this paper
• Structural insights into the multiple binding modes of Dimethyl Fumarate (DMF) and its analogs to the Kelch domain of Keap1

  2020cited by this paper
• Imaging Neurochemistry and Brain Structure Tracks Clinical Decline and Mechanisms of ALS in Patients

  2020cited by this paper
• Role of dimethyl fumarate in the treatment of glioblastoma multiforme: A review article

  2019cited by this paper
• Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stress

  2018cited by this paper
• Activation of Nrf2 attenuates carbonyl stress induced by methylglyoxal in human neuroblastoma cells: Increase in GSH levels is a critical event for the detoxification mechanism.

  2017influential reference
• The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2

  2017cited by this paper
• Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis

  2017cited by this paper
• Stearic acid based, systematically designed oral lipid nanoparticles for enhanced brain delivery of dimethyl fumarate.

  2017cited by this paper
• Multiple mechanisms of dimethyl fumarate in amyloid β‐induced neurotoxicity in human neuronal cells

  2017cited by this paper
• Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease

  2016cited by this paper
• Polysulfides protect SH-SY5Y cells from methylglyoxal-induced toxicity by suppressing protein carbonylation: A possible physiological scavenger for carbonyl stress in the brain.

  2016cited by this paper
• Dicarbonyl stress in cell and tissue dysfunction contributing to ageing and disease.

  2015cited by this paper
• Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease.

  2015cited by this paper
• Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.

  2015cited by this paper
• Methylglyoxal, the dark side of glycolysis

  2015cited by this paper
• Motor cortex glutathione deficit in ALS measured in vivo with the J-editing technique.

  2014cited by this paper
• Measurement of methylglyoxal by stable isotopic dilution analysis LC-MS/MS with corroborative prediction in physiological samples

  2014cited by this paper
• Significance of the rapid increase in GSH levels in the protective response to cadmium exposure through phosphorylated Nrf2 signaling in Jurkat T-cells.

  2014cited by this paper
• Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective.

  2012cited by this paper
• Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation.

  2012cited by this paper
• Enhanced carbonyl stress in a subpopulation of schizophrenia.

  2010cited by this paper
• Methylglyoxal, Glyoxal, and Their Detoxification in Alzheimer's Disease

  2005cited by this paper
• Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment

  2005cited by this paper
• Identification of Glyoxalase-I as a Protein Marker in a Mouse Model of Extremes in Trait Anxiety

  2005cited by this paper
• Inhibition of vesicular monoamine transporter enhances vulnerability of dopaminergic cells: relevance to Parkinson's disease.

  2005cited by this paper
• Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice

  2005cited by this paper
• Pharmacokinetics of oral fumarates in healthy subjects.

  2004cited by this paper
• Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice.

  2004cited by this paper
• Metformin inhibition of glycation processes.

  2003cited by this paper
• Identification of a Variant Antioxidant Response Element in the Promoter of the Human Glutamate-Cysteine Ligase Modifier Subunit Gene

  2002cited by this paper
• Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism

  2002cited by this paper
• Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal.

  2002cited by this paper
• Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications.

  1999cited by this paper
• Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide.

  1997cited by this paper
• Glutathione‐related enzymes in brain in Parkinson's disease

  1994cited by this paper
• The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins.

  1994cited by this paper

• Stigmasterol exerts antioxidant effects through activation of the Keap1/Nrf2 signaling pathway in Parkinson’s disease model

  2025cites this paper